ArticlePLOS digital health2026
Early identification of high-risk individuals for mortality after lung transplantation: A retrospective cohort study with topological feature engineering.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung transplantation remains the only definitive treatment for end-stage respiratory failure; however, it has substantial post-operative mortality risk. Current methods like the Lung Transplant Risk Index offer limited predictive performance. This study introduces a novel topological feature engineering model to assess mortality risk. The objective is to improve predictive accuracy by capturing complex temporal patterns while ensuring interpretability. A retrospective cohort study was conducted using clinical data from lung transplant recipients. The model integrates static and time-dependent variables through topological feature extraction, enabling sequential risk updating at transplantation, ICU admission, and throughout early post-operative course. Performance was compared to established methods using a held-out test set. Metrics included accuracy, sensitivity, specificity, and AUC. Interpretability was assessed using Shapley Additive explanations. The proposed model demonstrated superior predictive performance compared to traditional clinical risk scores (LTRI, CCI) and standard machine learning models. On the test dataset, it achieved 87.4% accuracy, 84.1% sensitivity, and 89.6% specificity, with an absolute AUC gain of 0.08 over the best non-topological baseline (p < 0.001). The model consistently outperformed existing approaches across subgroups including age, underlying disease, and transplant type. Shapley analysis revealed that dynamic variables such as early post-operative oxygenation trends, immunosuppressive load, and inflammatory markers were among the most critical contributors to mortality risk. The integration of topological features significantly enhances prediction of post-transplant mortality risk. These findings highlight topological transformers as a valuable tool for precision medicine and clinical decision support.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.